Neuropathic Pain

Latest News

Are Herbal Products Effective for Treating Neuropathic Pain?

According to the results of a recent review, there is “insufficient” evidence to conclude that either nutmeg or St John’s wort are effective in helping treat pain in neuropathic conditions.

Mirogabalin May Alleviate Pain Associated With Postherpetic Neuralgia

Mirogabalin was found to be safe, well tolerated, and effective at alleviating postherpetic neuralgia-associated pain.

Discord Found in Clinician-, Criteria-Based Fibromyalgia Diagnosis

There is disagreement between clinical diagnosis and criteria-based diagnosis of fibromyalgia.

Smoking Linked to Cognitive Dysfunction in Fibromyalgia

Smoking tobacco is a risk factor for cognitive dysfunction in patients with fibromyalgia.

Effective Diagnostic Screening Tests for Carpal Tunnel Syndrome

Investigators found that many people with carpal tunnel syndrome wake up at night with tingling and numbness in their fingers.

Short Segment Sensory Nerve Stimulation Offers Potential Diagnostic Value for Ulnar Neuropathy

The use of short-segment stimulation along the ulnar sensory nerves and across the elbow may provide reliable diagnostic confirmation of ulnar neuropathies.

Transcutaneous Electrical Nerve Stimulation Reduces Pain, Fatigue in Fibromyalgia

Transcutaneous electrical nerve stimulation administered during physical activity may effectively alleviate fibromyalgia-associated pain, fatigue, and disease impact in women.

Tegsedi Approved for Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis

The approval was based on data from the Phase 3 NEURO-TTR study (N=173) which randomized patients with polyneuropathy caused by hATTR amyloidosis to Tegsedi or placebo.

Optimizing Treatment for Patients With Chronic Sciatica: Gabapentin vs Pregabalin

In patients with chronic sciatica, gabapentin was associated with a greater reduction in leg pain intensity and fewer side effects compared with pregabalin.

FDA Fast-Tracks Non-Opioid Treatment for Neuropathic Pain

The treatment is currently being evaluated in a Phase 2 study (ELEVATE) in patients with major depressive disorder who have had an inadequate response to standard antidepressant therapy.